Terms: = Uterine cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
6 results:
1. Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
Gebrie A
PLoS One; 2022; 17(7):e0268480. PubMed ID: 35895593
[TBL] [Abstract] [Full Text] [Related]
2. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
3. Deregulation of LIMD1-vhl-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
[TBL] [Abstract] [Full Text] [Related]
4. miR-21-3p is a positive regulator of L1CAM in several human carcinomas.
Doberstein K; Bretz NP; Schirmer U; Fiegl H; Blaheta R; Breunig C; Müller-Holzner E; Reimer D; Zeimet AG; Altevogt P
Cancer Lett; 2014 Nov; 354(2):455-66. PubMed ID: 25149066
[TBL] [Abstract] [Full Text] [Related]
5. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract] [Full Text] [Related]
6. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
[TBL] [Abstract] [Full Text] [Related]
